MSK Department of Medicine
@MSK_DeptOfMed
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag
A new study from Anthony Yu, Chau Dang, and @JLiu_MSKCardOnc evaluated the cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted treatment. @MSKCancerCenter @JACCJournals #cancer jacc.org/doi/10.1016/j.…
🚨Today, in @NatureCancer, we show that CAR-T cells and CAR-NK cells contain the seeds of their own self-destruction. Disruption of a FAS-L/FAS circuit enhances CAR potency against liquid and solid cancers. rdcu.be/exjEy @MSKCancerCenter @parkerici @MSK_DeptOfMed
That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn @MSKCancerCenter
It’s my great honor to write the editorial for the pivotal MATTERHORN study @NEJM @YJanjigianMD @ASCO More global collaboration is needed to further improve outcomes for our patients with gastric/GEJ cancer.@OncoAlert @oncodaily nejm.org/doi/full/10.10…
Always an honor and delight for @MSKCancerCenter @MSK_DeptOfMed @EileenMOReilly @GABOUALFA to join with our dear @AUB_Lebanon @AUBMC_Official and @burjeelhospital @alshamsi2000 Hassan Ghazal @cmc_dubai @GhosnMd and other colleagues for the @ASCO #bestofasco2025!
Delighted to share our review paper on the treatment of MZL published @BloodPortfolio. Great collaboration with @ArielaNoyMD @MSK_DeptOfMed @MSKCancerCenter @SylvesterCancer @UMiamiHealth ashpublications.org/blood/article-…
🎉 Today we welcome the 2025 cohort of #Postbac MSK Bridge Scholars! We’re thrilled to have them join us for the next 2 years of #biomedical #research training and educational support. RT to help us give a warm welcome to our #MSKBridge Scholars! 🙌
🫁 Check out our #ASCO25 interview with Shriya Garg of the University of Georgia and @EChrisDee of @MSKCancerCenter, covering their research on palliative intent lung cancer disparities in disaggregated Hispanic patient populations! ➡️ Learn more: buff.ly/z4glqqv #lcsm
New research from MSK investigates whether introducing new mutations could make #immunotherapy more effective against some cancers; shows that people in their 90s who underwent #lungcancer surgery had positive outcomes; shares lessons on the responsible governance of #AI in…
Join us for Optimizing Gastrointestinal Care in the Cancer Patient: A Gastroenterologist’s Toolkit. This one-day course @MSKCancerCenter will provide a comprehensive update on the diagnosis, management, and surveillance of precancerous and malignant GI disorders, covering the…
Excited to present our work! Thanks for this opportunity and looking forward to a great conference #WorldGU25 @MSK_DeptOfMed @MSKCancerCenter
Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. hubs.la/Q03wLfxZ0…
Just out in @ASTCT: Updated allogeneic stem cell donor selection guidelines from the CIBMTR/NMDP. Kudos to @mskcancercenter's @BrianShafferMD and team! #stemcelltransplant #Cancer sciencedirect.com/science/articl…
Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD @JACCJournals @ksase @dineshpmcc1 @ICOSociety
MSK researchers are working to better understand #metastasis and pointing toward new opportunities for potential #cancer treatments. “At MSK, we are attacking the problem from all sides,” says MSK Chief Scientific Officer Dr. Joan Massagué. "Our ultimate goal is to turn…
NEW in @NatureMedicine: a study led by MSK & @IcahnMountSinai suggests that #AI could significantly improve how tumor samples are analyzed in the lab using a model trained to identify #LungCancer mutations. The approach cut the number of molecular tests needed by up to 43% while…
Join us for the 2025 Emergencies in the Cancer Patient course. Now in its sixth year, this highly regarded program brings together experts from across the cancer care continuum to share practical, case-based strategies for recognizing and managing oncologic emergencies. We’re…
Last breath of critical data before summer. Join us! Register at gotoper.com/courses/oncolo…)
Thank you @MSK_DeptOfMed ! I will always carry my @MSKCancerCenter experience with me and I look forward to continued collaborations with MSK’s amazing scientists and physicians, who I am fortunate to call friends.
Best of luck, @Neil_Iyengar! Thank you for everything you have done for MSK. We can't wait to follow your journey and see all the amazing things you will continue to do.
This morning at #ESMOGI25, @YJanjigianMD chaired an education session on #gastroesophagealcancer. Discover how her research on immunotherapies to treat these cancers is changing the standard of care: bit.ly/44bZHJS @MSKCancerCenter
